Results 201 to 210 of about 348,517 (305)

p16 Overexpression and Human Papillomavirus Positivity in More Than 1000 Penile Cancers

open access: yesInternational Journal of Cancer, Volume 159, Issue 12, Page 3029-3037, 15 December 2026.
ABSTRACT Penile cancer is a severe disease, and a large proportion is related to high‐risk (hr) human papillomavirus (HPV). P16 is used as an immunohistochemical marker of HPV in clinical diagnostics. Population‐based data on the prevalence of p16 in penile cancer is scarce.
Marianne Gardar Stærk   +12 more
wiley   +1 more source

Immunometabolic Modulation by Low‐Dose Sodium Butyrate: PI3K/Akt/mTOR Signalling Orchestrates Macrophage Polarization to Protect Against Clostridioides difficile Colitis

open access: yesImmunology, Volume 179, Issue 4, Page 594-608, December 2026.
Clostridioides difficile toxins TcdA and TcdB enter intestinal epithelial cells (IECs) via specific receptors, disrupt tight‐junction integrity and activate PI3K/Akt/mTOR signalling, promoting inflammasome assembly and IL‐1β release. Toxin‐induced IEC apoptosis further weakens the epithelial barrier.
Sisi Zhang   +7 more
wiley   +1 more source

Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines. [PDF]

open access: yesBiosaf Health
Liu Z   +11 more
europepmc   +1 more source

Irradiation‐Induced CD62L Shedding in Human Plasmacytoid Dendritic Cells Depends on ADAM17 and p38 MAPK

open access: yesImmunology, Volume 179, Issue 4, Page 671-681, December 2026.
Human plasmacytoid dendritic cell‐based vaccines efficiently migrate from blood to lymph nodes and prime naive T cells in humanised mice. Irradiation‐induced CD62L shedding, mediated by p38 MAP kinase and ADAM17, is involved in the regulation of PDC migration to secondary lymphoid organs in this model.
Estelle Leplus   +11 more
wiley   +1 more source

Vaccine Side Effects Following COVID-19 Vaccination with Inactivated Vaccines in Zimbabwe

open access: yes, 2022
Makadzange AT   +9 more
europepmc   +1 more source

A Confirmatory, Dual Center Nonhuman Primate Study on the Efficacy of Novel Oropharyngeal Spray Immunization With an Adenoviral Vector Vaccine Against RSV—Important Lessons Learned

open access: yesJournal of Medical Primatology, Volume 55, Issue 6, December 2026.
ABSTRACT Background In a randomized, blinded, dual center study across two European primate research facilities, we evaluated the immunogenicity and protective efficacy of a DNA prime—oropharyngeal adenoviral boost vaccination strategy against respiratory syncytial virus (RSV).
Matthias Tenbusch   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy